SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is currently the focus of intense market conversation as investors keenly await its impending earnings report, with community sentiment weighing high expectations for continued AI-driven growth against concerns of a 'priced to perfection' valuation and significant options volatility.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is drawing significant attention as the community eagerly anticipates new hyperscaler lease announcements and key earnings reports from NVIDIA and CoreWeave. Discussions revolve around the stock's high short interest and its strategic position within the booming AI data center infrastructure sector amidst recent market volatility.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle (CRCL) is experiencing a sharp surge driven by a strong Q4 earnings beat, which revealed impressive growth in USDC adoption and transaction volume, triggering a significant short squeeze amidst intense community debate over its long-term financial infrastructure potential.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio (IBRX) is facing extreme volatility and a significant price pullback, sparking intense community debate over whether the drop is a "healthy correction" or a "pump and dump" following its recent 700% revenue surge and global approvals for its cancer treatment, Anktiva. Bulls highlight strong fundamentals and upcoming ASCO data, while bears raise concerns about valuation and alleged market manipulation.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Bozeman, MT.

Snowflake Inc

Snowflake is a top trending stock due to its imminent earnings report, fueling intense community debate over potential impacts and future guidance. This comes as a new $200 million multiyear partnership with OpenAI highlights its role as an AI enabler, though some investors fear broader AI disruption and competition could challenge its valuation and margins within the software sector.

Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.

Larimar Therapeutics Inc

Its Friedreich's ataxia treatment has received FDA Breakthrough Therapy Designation, signaling potential for accelerated approval and exciting the community with its disease-modifying potential. Investors are actively discussing significant analyst price target increases, a high short interest suggesting a potential squeeze, and the possibility of a buyout.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce is experiencing intense investor focus ahead of its pivotal earnings report, driving a sharp community debate on whether its integrated AI strategy will counter broad SaaS sector disruption fears or face significant competitive pressures from emerging AI solutions.

Oddity Tech Ltd. engages in the online retail sale of cosmetics and beauty products. Its products include lipsticks, makeup brushes, mascara, eyelash curlers, and makeup brush cleansers. The company was founded by Oran Holtzman and Shiran Holtzman-Erel on March 23, 2013 and is headquartered in Tel Aviv, Israel.

ODDITY Tech Ltd. - Ordinary Shares - Class A

ODDITY Tech is trending after its stock plummeted following guidance for a significant Q1 revenue decline, attributed to an advertising "algo snafu." The community is sharply divided, with some buying the dip and hoping for a strong recovery, while others express deep skepticism about management's explanation and fear further downside.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

The Trade Desk is heavily discussed as its Q4 earnings approach, with investors fiercely debating whether the ad-tech leader, currently seen as deeply undervalued by many, will finally rebound from its sustained decline or face further pressure from competitive headwinds and management skepticism.

Eton Pharmaceuticals, Inc. engages in the development, acquisition, and commercialization of prescription drug products. Its products include Biorphen, Alaway Preservative Free, zonisamide oral suspension, topiramate oral suspension, lamotrigine for oral suspension, cysteine injection, and ephedrine ready-to-use injection. The company was founded in April 2017 and is headquartered in Deer Park, IL.

Eton Pharmaceuticals Inc

Eton Pharmaceuticals is trending following recent FDA approval for DESMODA, the first ready-to-use liquid medicine for central diabetes insipidus; however, the community is debating a 'sell the news' reaction and potential short pressure despite the positive catalyst and the company's rare disease focus.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Oculis (NASDAQ:OCS) Hits New 1-Year High - Here's Why

Oculis (NASDAQ:OCS) Reaches New 52-Week High - Here's What Happened...

Oculis Holding AG (NASDAQ:OCS) Receives Consensus Rating of "Moderate Buy" from Analysts

Shares of Oculis Holding AG (NASDAQ:OCS - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the nine research firms that are covering the stock, MarketBeat.com reports...

Oculis (NASDAQ:OCS) Hits New 12-Month High - Time to Buy?

Oculis (NASDAQ:OCS) Hits New 52-Week High - Here's Why...

Oculis (NASDAQ:OCS) Hits New 12-Month High - Should You Buy?

Oculis (NASDAQ:OCS) Hits New 52-Week High - Still a Buy...

Oculis (NASDAQ:OCS) Reaches New 1-Year High - Here's Why

Oculis (NASDAQ:OCS) Hits New 1-Year High - Here's What Happened...

Oculis (NASDAQ:OCS) Shares Gap Up - What's Next?

Oculis (NASDAQ:OCS) Shares Gap Up - What's Next...

Oculis (NASDAQ:OCS) Shares Gap Up - Should You Buy?

Oculis (NASDAQ:OCS) Shares Gap Up - Here's What Happened...

Short Interest in Oculis Holding AG (NASDAQ:OCS) Increases By 105.6%

Oculis Holding AG (NASDAQ:OCS - Get Free Report) saw a significant growth in short interest in December. As of December 15th, there was short interest totaling 101,167 shares, a growth of 105.6% from...

Oculis (NASDAQ:OCS) Shares Down 4.3% - Time to Sell?

Oculis (NASDAQ:OCS) Trading Down 4.3% - Should You Sell...

Oculis (NASDAQ:OCS) Shares Gap Up After Analyst Upgrade

Oculis (NASDAQ:OCS) Shares Gap Up After Analyst Upgrade...

Oculis Holding AG is a global biopharmaceutical company, which engages in sight and improving eye care. The firm's pipeline includes multiple product candidates in development such as, OCS-01, a topical retinal candidate for diabetic macular edema, OCS-02, a topical biologic candidate for dry eye disease, and OCS-05, a disease modifying candidate for acute optic neuritis and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The company was founded in 2016 and is headquartered in Zug, Switzerland.

Oculis Holding AG

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

Ahead of earnings, sentiment is split between blowout AI growth and concerns around macro pressure, positioning, and post-ER volatility. How do you see it playing out?

Current Price	$29.44
Prev Close	$29.63
Open	$29.68
Dividend Yield	0.00%
50-Day Moving Average	$24.62
Beta	0.84
Avg. Volume	306,119.55
PE Ratio	-11.77

52-Week High	$29.80
52-Week Low	$14.00
Market Capitalization	$1.8B
EPS (Annual)	-$2.41
Price to Book	9.45
Revenue Per Employee	$0.00

OCS
Oculis Holding AG

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest OCS News

OCSOculis Holding AG